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Heparin anticoagulation during cardiovascular surgical procedures remains poorly investigated and understood. The 
objective of this investigation was to assess the effectiveness of three methods of heparin administration. Heparin sulfate (75 
IU/kg) administered to patients undergoing aortoiliac surgery was randomised to one of three methods: Group I (n = 9) 
heparin was injected into a central venous line 5 minutes before infrarenal aortic clamping; Group II (n = 9) heparin was 
injected into the distal aneurysm immediately after infrarenal aortic clamping; and Group III (n = 8) heparin was injected 
into a central venous line immediately after infrarenal aortic clamping. Blood samples were analysed for anticoagulant 
activity from both the upper and lower extremities at 5, 15, 30, 60, and 120 minutes after heparin administration. 
Anticoagulation, as measured by aPTT, antifactor Xa levels, and ACT, was achieved in all three groups by 5 minutes, but 
initially with lower heparin activity (measured as antifactor Xa) in the upper extremity (Group II) and lower extremity 
(Group III), respectively. These differences were also evident in ACT and aPTT determinations. Intravenous heparin 
administration prior to aortic cross-clamping achieves excellent anticoagulation (anti-factor Xa ~ 1 U/ml) in both upper 
and lower extremities after 5 minutes. With regional administration, rapid heparin redistribution occurs, but it takes longer 
to achieve the same level of anticoagulation distant from the site of administration. Nevertheless, from a practical 
perspective the method of administration does not appear to have a great influence on the eventual achievement of adequate 
anticoagulation. 
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Introduction 
Intraoperative thrombosis may complicate major car- 
diovascular reconstructions, especially those involv- 
ing aortic cross-clamping. Heparin sulfate is used to 
prevent such thrombotic complications. However, 
opinions vary widely among surgeons about the time 
interval after heparin administration that is necessary 
before adequate anticoagulation is achieved. The route 
of administration in relation to aortic cross-clamping; 
intravenous versus intra-aortic, is also a point of 
frequent discussion. Likewise, it is not known if it is 
worthwhile to repeat heparin administration during 
aortic cross-clamping and if such administration will 
be properly redistributed. This study focuses on the 
time-related effects of heparin administration during 
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aortic cross-clamping in patients undergoing vascular 
surgery. 
Material and Methods 
Twenty-six patients undergoing elective infrarenal 
aortic aneurysmectomy were randomly allocated to 
three study groups: Group I (n = 9) were given 75 IU/  
kg heparin intravenously into a central venous cathe- 
ter 5 minutes prior to aortic clamping; Group II (n = 9) 
were given 75 IU/kg  heparin into the aneurysm at the 
time of aortic clamping; and Group III (n = 8) were 
given 75 IU/kg  heparin intravenously into a central 
venous catheter at the time of aortic clamping. The 
groups were well matched with no significant differ- 
ences regarding age (mean age 73 years), gender, or 
operative blood loss (mean 1,800 ml), fluid admini- 
stration and intraoperative transfusion requirements. 
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During the operat ion 500 ml dextran (Rheomacro- 
dex ®, Pharmacia AB, Uppsala, Sweden) was admin- 
istered over  a 3 to 4 hour  per iod of time. Citrated 
blood samples from one radial ar tery and one femoral  
vein were obtained as baseline values just prior  to 
heparinisat ion and 5, 15, 30, 60, and 120 minutes 
thereafter. Activated clotting t ime (ACT, max imum 
400 seconds) was assessed using tubes containing 12 
mg diatomaceous earth and a small magnet.  The ACT 
was de termined in seconds with an electronic clot 
t imer (Hemochron,  International Technydine Corp, 
Metuchen,  NJ, U.S.A.). Addit ional  plasma samples 
were frozen and analysed later for aPTT and antifactor 
Xa levels using a chromogenic substrate technique. All 
analyses were per formed at the Depar tment  for 
Coagulation Disorders, Malm6 General Hosp i t a l  
Lund  University, Malm6, Sweden. 
The s tudy was approved by  the Ethics Commit-  
tee, Lund  University. Statistical analyses included 
analyses of variance (ANOVA) for non-parametr ic  
data and Student 's t-test for differences between 
groups; p < 0.05 was considered significant. 
Results 
Equal prolongat ion of ACT after 5 minutes was 
obtained in Group I in the upper  and lower extrem- 
ities, bu t  in Groups II and III higher levels (p < 0.05) 
were seen after 5 minutes in the lower (II) and upper  
Table 1. ACT levels  in vascular surgery patients 
Group I Group II Group III 
Upper extremity 
Baseline 160±4 160±7 167±7 
5min 276±17 222±16 292±22 
15min 272±13 235±11 264±13 
30min 269±16 243±11 270±16 
60min 225±12 230±18 242±15 
120min 203±10 215±15 221±21 
Lower extremity 
Basefine 164±6 159±10 165±8 
5min 262±15 263±33 231±22 
15min 278±17 299±33 264±18 
30min 261±10 310±25 251±14 
60min 252±17 255±27 259±12 
120min 193±7 212±25 202±31 
Group I central venous heparin administration 5 minutes before 
aortic clamping; Group II intra-aneurysmal heparin administration 
at aortic clamping; Group III central venous heparin administration 
at aortic clamping, (Mean+S.D.) 
(III) extremities, respectively (Table 1). This was also 
evident  in differences in antifactor Xa levels (Figs 1 to 
1,5 
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Fig. 1. Anti-Factor Xa activity following central venous heparin 
administration 5 minutes before aortic clamping (Group I). 
3). The highest heparin level achieved was approx- 
imately 1.2 un i t /ml .  The aPTT levels showed no 
difference between uppe r  and lower  extremity sam- 
ples in group I, whereas there was a tendency in the 
lower and upper  extremities in Groups II and III, 
respectivel3~ for the values to be higher  (Table 2). The 
antifactor Xa levels remained slightly elevated after 
120 minutes to about  0.2 IU/ml .  However ,  the aPTT 
levels showed a more marked  prolongation 120 
minutes after heparin administration. Blood samples 
from the femoral vein 15 minutes after heparin 
administrat ion in one patient were not obtained, and 
in another  two patients heparinisat ion was reversed 
within 60 minutes. No difference in baseline values 
were seen between venous  and arterial blood 
samples. 
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Fig. 2. Anti-Factor Xa activity following intra-aneurysmal heparin 
administration at the time of aortic clamping (Group II). 
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Fig. 3. Anti-Factor Xa activity following central venous heparin 
administration at the time of aortic clamping (Group III). 
Discussion 
Recent articles dealing with hepar in  dynamics docu- 
ment  a wide variety of results regarding anticoagula- 
12 tion dur ing cardiovascular surgery. " Hepar in  given 
intravenously has an in vivo half-life that is considered 
dose-dependent .  3 Some studies have demonstra ted a 
quick rise to max imum ACT and prothrombin-t ime 
values within 1 minute  after hepar in  administration, 4 
while others suggest a much  longer time is necessary 
to achieve adequate anticoagulation. 5 Effeney and 
colleagues found that max imum anticoagulation fol- 
lowing heparin administrat ion occurred in 5 to 24 
minutes in peripheral  vascular surgery patients, c o m -  
Table 2. APTT leveIs  in vascular  surgery patients  
Group I Group II Group III 
Upper extremity 
Baseline 39-+2 49-+8 42-+3 
5min 300 182_+45 283_+17 
15min 300 275_+26 300 
30min 261_+26 280_+20 273_+27 
60min 205±44 246±36 259±28 
120min 160_+51 227_+46 212_+65 
Lower extremity 
Baseline 41 _+3 44+7 42-+2 
5 min 300 261-+36 184-+44 
15 min 300 300 261+26 
30 rain 300 300 300 
60 rain 240+_39 262_+32 300 
120 min 146_+46 216_+52 211+53 
Group I central venous heparin administration 5 minutes before 
aortic clamping; Group II intra-aneurysmal heparin administration 
at aortic clamping; Group III central venous heparin administration 
at aortic camping, (Mean+S.D.). Maximum value was 300 
seconds. 
pared to 10 to 34 minutes in cardiac surgery patients. 6 
This is in contrast to our  findings where  adequate  
anticoagulation was obtained within minutes after 
heparin administration, with less initial prolongat ion 
in areas distant from the site of administration. 
However ,  in our  studies heparin distribution and 
adequate  anticoagulation was universal ly achieved in 
all instances by  15 minutes. It seems reasonable to 
assume that repeat  heparin administered dur ing  a 
vascular procedure  will be distr ibuted also to tissues 
beyond  a c lamped vessel. In a canine s tudy using 
similar methods  of heparin administrat ion as in the 
present stud)~ complete anticoagulation was achieved 
within 5 minutes with all three methods  of administra- 
tion in both  upper  and lower extremities. 7 
We assessed the state of anticoagulation using the 
ACT test, since it is frequently used intraoperat ively to 
establish the effectiveness of anticoagulation. The ACT 
responds in a linear fashion to increasing hepar in  
dosage and correlates well with observed clinical 
anticoagulation, such as with use of thrombus-free 
card iopulmonary  bypass  equipment,  s Adequate  anti- 
coagulation for extracorporeal  circulation is defined as 
an ACT prolongat ion of more than 480 seconds, but  
most  clinicians would  agree that any value between 
300 and 600 seconds is acceptable. 9 For most  peripher-  
al vascular procedures,  values be tween 200 and 250 
seconds are considered appropriate.  This level of 
anticoagulation was p rompt ly  achieved in our  s tudy  
and maintained dur ing  the 120 minute  followup. 
Likewise, accepted adequate anticoagulation may  be 
defined by  an aPTT of 2.5 or greater than control 
values, z°' ~ As was the case with ACT levels in the 
present  s tud~  these aPTT values were achieved and 
maintained th roughout  the 120 minute  followup. 
Hepar in  effects were also de termined in the 
present s tudy by  measuring the antifactor Xa levels. 
Maximal values measured  were slightly greater than 1 
U/ml ,  which are in accordance with findings of 
others, X2, 23 al though our  decline of antifactor Xa levels 
was slightly less than repor ted earlier. Antifactor Xa 
levels at 120 minutes in our  s tudy  were approximately  
0.2 U /m l ,  while others using a slightly higher  hepar in  
dose observed a lower peak level, but  values of 
approximately  0.4 U / m l  at 120 minu te s )  2 The accept- 
ed range of heparin activity for effective anticoagula- 
tion is be tween 0.2 and 1.0 antifactor Xa U / m l  plasma, 
which was achieved dur ing the 120 minute  per iod 
after hepar in  administrat ion in the current study. 
This s tudy supports  the tenet that adequate  
anticoagulation dur ing  aortic reconstructive surgery is 
obtained within 5 minutes after systemic hepar in  
administration. Regional heparin administrat ion at 
the t ime of aortic cross-clamping requires slightly 
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longer time for heparin distribution and subsequent 
adequate anticoagulation in both the upper and lower 
extremities. Aortic cross-clamping can be safely per- 
formed at 5 minutes after heparin administration, and 
extrapolating from previously reported canine data 
probably can be performed as early as 1 minute after 
intravenous heparin administration. Heparin distribu- 
tion after regional administration suggests that repeat- 
ed administration during prolonged vascular occlu- 
sions should allow for adequate anticoagulation distal 
to the clamped vessel, albeit with a longer period of 
time necessary to achieve maximum anticoagulation. 
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